EP Patent

EP1438974A2 — pH-sensitive liposomes based on diacyl-glycero-phosphoethanolamine and diacyl-succinyl-glycerol

Assigned to GE Healthcare AS · Expires 2004-07-21 · 22y expired

What this patent protects

The invention relates to pH-sensitive liposome systems, compositions comprising said pH sensitive liposome systems and the use of such compositions as contrast agents and medicaments. Surprisingly, we have found a pH sensitive liposome system comprising (a) 1-acyl-2-acyl…

USPTO Abstract

The invention relates to pH-sensitive liposome systems, compositions comprising said pH sensitive liposome systems and the use of such compositions as contrast agents and medicaments. Surprisingly, we have found a pH sensitive liposome system comprising (a) 1-acyl-2-acyl-glycero-3-phosphoethanolamine and (b) 1-acyl-2-acylsuccinylglycerol or 1-acyl-3-acylsuccinylglycerol wherein in (a), both acyl-residues are the same or different and are saturated acyl residues that contain at least 14 C atoms or, one acyl residue is a saturated acyl residue that contains at least 14 C atoms and the other acyl residue is a monounsaturated acyl residue that contain at least 14 C atoms and, wherein in (b), both acyl-residues are the same or different and are saturated acyl residues that contain at least 14 C atoms or, one acyl residue is a saturated acyl residue that contains at least 14 C atoms and the other acyl residue is a monounsaturated acyl residue that contain at least 14 C atoms, that could be used for the preparation of pH sensitive MR contrast agents that are suitable for in vivo applications.

Drugs covered by this patent

Patent Metadata

Patent number
EP1438974A2
Jurisdiction
EP
Classification
Expires
2004-07-21
Drug substance claim
No
Drug product claim
No
Assignee
GE Healthcare AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.